OTTAWA, Jan. 20, 2012 /CNW/ - Rx&D President Russell Williams made the following statement to complement the joint announcement made by Western Economic Diversification Canada and Pfizer Canada Inc. of $500,000 each towards the Alberta Pfizer Collaboration Fund.
"Today's investment is another example of how Government and industry can come together to drive innovation - translating today's research into new medicines and therapies tomorrow.
"Collaboration with universities and research hospitals, support for innovation and help to commercialize new ideas are critical for Alberta's knowledge-based economy. In 2010, Rx&D members invested $1.3 billion in life science research and development across Canada.
"These public-private partnerships strengthen Canada's position as a world leader in life sciences. Rx&D members are proud to be one of the leading investors in the sector and we are committed to continue investing in innovative health care solutions that help Canadians live longer, feel better and lead more productive lives.
Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.
For further information: